Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402K Sell
3,125
-2,071
-40% -$242K 0.34% 32
2026
Q1
$625K Sell
5,196
-112
-2% -$12.9K 0.53% 27
2025
Q4
$559K Buy
+5,308
New +$498K 0.55% 30

Other funds holding MRK

Corecam AG's MRK Position: Q2 2026 in Review

Corecam AG reduced its Merck (MRK) stake by 40% in Q2 2026, selling an estimated $242K and leaving 3,125 shares worth $402K. The position accounts for 0.34% of the portfolio, ranked #32.

Corecam AG first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $625K in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Corecam AG held 3,125 shares of Merck worth $402K as of Q2 2026.
  • Corecam AG sold 2,071 Merck shares in Q2 2026, an estimated $242K.
  • Merck made up 0.34% of Corecam AG's portfolio in Q2 2026, its #32 holding.
  • Corecam AG first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Corecam AG's Merck position peaked at $625K in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Corecam AG's 13F filing for Q2 2026, filed 17 Jul 2026.